Atrial Fibrillation

Post-procedure AF, once thought to be an artifact of healing, turns out to be a sign of significant risk, a new study finds.

The path to reducing risk of stroke in AF patients is far from straight and narrow. A case and 3 questions test your clinical navigation skills.

Consider this case of a 92-year-old man who presents with permanent atrial fibrillation and multiple comorbidities. Should he be anticoagulated?

A 76-year-old woman with drug eluting stent placed post-STEMI will need an antiplatelet regimen. What would you recommend?

Results of the largest study to assess impact of left atrial appendage closure during routine non-AF-related cardiac surgery raise a few new questions.  

A small single-center study yields provocative results that may help increase understanding of the importance of the left atrial appendage. 

A recent study finds an unexepcted association between the CVD biomarker lipoprotein(a), atrial fibrillation, and stroke. 

A topline review of 3 more of the top 6 studies of 2017 in afib includes the death of digoxin, go and no-go foods, and afib and ESRD.   

Cardiologist and Patient Care author Payal Kohli, MD offers snap shots of 6 influential studies that will affect the future of AF diagnosis and treatment.

Bleeding and "mysterious" sginal for MI seen in RE-LY persist. Message: continue to weigh risk vs benefit. 

Study net-net: Account for kidney function when dosing the direct oral anticoagulants -- but also account for an agent's potential renal harm.

Is this patient, status post motor vehicle accident, at risk for developing atrial fibrillation?

You're finishing rounds on Friday and are called to the ICU to consult on a case of Afib. The patient is a surprise and the residents have questions. Good luck!

Which drugs taken concurrently with the new oral anticoagulants put patients with Afib at greatest increased risk for major bleeding?

A first-of-its-kind study reports an association between T1DM and AF, and between glycemic control and AF. Plus, there are gender differences.

That depends, as suggested by results of the CASTLE-AF study, presented at ESC Congress 2017, in Barcelona, Spain.

Diagnosis of atrial fibrillation via handheld iECG monitor looks promising but can we pay for it yet?

A small study raises big questions about patients' perceptions of AF symptoms after pulmonary vein ablation. What do you think?

Increased detection of subclinical atrial fibrillation intensifies a common clinical quandary in AF patients: to anticoagulate, or not?

Rhythm vs rate control and which medication(s) for which patients, when, and why? Test yourself.

Medicine is finally catching up with the smartphone/smartwatch era – and it’s about time!

Does coffee increase AF risk? How about chocolate? Marijuana? Test yourself with our quiz so you can counsel your patients.

Mr Smith is 66-years-old. How would you treat his arrhythmia? What would you choose for anticoagulation?

Digoxin is used in nearly 30% of patients with AF but has never been studied for safety/efficacy in this population, until now.

See what you know about optimal co-management when the patient with hypertension also has Afib, CAD, or heart failure.

Your atrial fibrillation spot quiz of the week -- take a minute and try these 3 short questions.

Some call this new study a "game changer" when it comes to AF patient selection for direct-acting oral anticoagulant Rx. What's your take?

Is exercise safe in HF patients who have AF? Results of the HF-ACTION study are summarized in this short slide show.

A study of a global registry finds that prescriptions for direct oral anticoagulants have now surpassed those for VKAs. What do you Rx?

Patients who require dose adjustment when taking direct oral anticoagulants have not been well studied. This large study is a good start.